Published in J Neurol on April 15, 2009
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet (2007) 7.27
Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet (2007) 6.29
Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke (2001) 4.87
A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol (2007) 3.56
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46
Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke (1990) 3.43
Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol (2007) 3.19
Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke (1990) 3.15
Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke (2007) 2.63
The prognosis of hospital-referred transient ischaemic attacks. J Neurol Neurosurg Psychiatry (1991) 1.73
Rapid identification of high-risk transient ischemic attacks: prospective validation of the ABCD score. Stroke (2008) 1.72
Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis (2003) 1.70
Impact of abnormal diffusion-weighted imaging results on short-term outcome following transient ischemic attack. Arch Neurol (2007) 1.61
An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke. Int J Stroke (2008) 1.43
Risk of ischemic heart disease in patients with TIA. Neurology (1984) 1.21
Long term risks of stroke, myocardial infarction, and vascular death in "low risk" patients with a non-recent transient ischaemic attack. J Neurol Neurosurg Psychiatry (2003) 1.20
Outcome of 314 patients with transient ischemic attacks. Stroke (1982) 1.05
Why is the outcome of transient ischaemic attacks different in different groups of patients? BMJ (1993) 0.96
Etiology, duration, and prognosis of transient ischemic attacks: an analysis from the German Stroke Data Bank. Arch Neurol (2002) 0.91
A prospective reevaluation of transient ischemic attacks as a risk factor for death and fatal or nonfatal cardiovascular events. Stroke (1994) 0.85
Survival after stroke and transient ischemic attacks during the 1970s and 1980s. Stroke (1989) 0.82
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation (2011) 6.48
Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med (2014) 5.44
NXY-059 for acute ischemic stroke. N Engl J Med (2006) 5.32
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med (2004) 4.39
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache (2010) 4.37
NXY-059 for the treatment of acute ischemic stroke. N Engl J Med (2007) 3.70
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. JAMA (2005) 3.54
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke (2012) 3.02
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77
Frovatriptan for prophylactic treatment of cluster headache: lessons for future trial design. Headache (2010) 2.72
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J (2016) 2.70
Lifting the burden: the first 7 years. J Headache Pain (2010) 2.55
Migraine and risk of cardiovascular disease in men. Arch Intern Med (2007) 2.49
Responsiveness of efficacy endpoints in clinical trials with over the counter analgesics for headache. Cephalalgia (2012) 2.46
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial. Ann Intern Med (2011) 2.45
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace (2015) 2.35
Practical experiences on the necessity of external validation. Stat Med (2007) 2.09
Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis. Cephalalgia (2011) 2.07
Obesity and recurrent vascular risk after a recent ischemic stroke. Stroke (2011) 2.04
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol (2012) 1.99
Headache disorders are third cause of disability worldwide. J Headache Pain (2015) 1.93
Predicting functional outcome and survival after acute ischemic stroke. J Neurol (2002) 1.92
Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J (2007) 1.90
The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the Global Campaign against Headache. J Headache Pain (2014) 1.88
Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache (2006) 1.86
Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale. Am Heart J (2010) 1.76
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75
Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. Stroke (2004) 1.69
Cluster headache: clinical features and therapeutic options. Dtsch Arztebl Int (2011) 1.69
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial. Cephalalgia (2010) 1.67
Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study. Lancet Neurol (2012) 1.67
Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire. J Headache Pain (2014) 1.63
Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J (2012) 1.62
Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial. J Hepatol (2006) 1.54
Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke (2010) 1.53
Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation. J Headache Pain (2014) 1.53
The Global Campaign, World Health Organization and Lifting The Burden: collaboration in action. J Headache Pain (2011) 1.52
Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials. Stroke (2007) 1.52
Prevention of medication overuse in patients with migraine. Pain (2010) 1.51
Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice. Thromb Haemost (2012) 1.51
The pathogenetic significance of intestinal Candida colonization--a systematic review from an interdisciplinary and environmental medical point of view. Int J Hyg Environ Health (2002) 1.50
Molecular junctions based on aromatic coupling. Nat Nanotechnol (2008) 1.48
Assessment of functioning and disability after ischemic stroke. Stroke (2002) 1.48
Time to act on headache disorders. J Headache Pain (2011) 1.47
Factors predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramate. Cephalalgia (2010) 1.43
Medication overuse headache. Expert Opin Drug Saf (2006) 1.42
Development and validation of the EUROLIGHT questionnaire to evaluate the burden of primary headache disorders in Europe. Cephalalgia (2010) 1.40
Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol (2005) 1.40
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace (2016) 1.39
Why should American headache and migraine patients still be treated with butalbital-containing medicine? Headache (2012) 1.38
Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner. J Immunol (2008) 1.36
Headache and emergency medicine: sharing a language for a common project. Intern Emerg Med (2008) 1.36
Development and validation of the Essen Intracerebral Haemorrhage Score. J Neurol Neurosurg Psychiatry (2005) 1.34
The Virtual International Stroke Trials Archive. Stroke (2007) 1.34
Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt. Cerebrovasc Dis (2009) 1.34
Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation. J Headache Pain (2014) 1.31
Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke (2007) 1.26
Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study. Stroke (2013) 1.25
Complications following acute ischemic stroke. Eur Neurol (2002) 1.25
Acupuncture for tension-type headache: a multicentre, sham-controlled, patient-and observer-blinded, randomised trial. J Headache Pain (2007) 1.22
Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke. Stroke (2005) 1.22
Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial. Stroke (2011) 1.22
Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain (2011) 1.19
Framing education on headache disorders into the Global Burden of Disease Study 2010. The European Headache Federation stands ready. J Headache Pain (2013) 1.19
Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia. Arch Neurol (2006) 1.17
Morphometric changes of sensorimotor structures in focal dystonia. Mov Disord (2007) 1.17
The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain (2014) 1.17
The Global Burden of Disease survey 2010, Lifting The Burden and thinking outside-the-box on headache disorders. J Headache Pain (2013) 1.17
Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. Lancet Neurol (2010) 1.16
Role of acupuncture in the treatment of migraine. Expert Rev Neurother (2007) 1.15
Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients study. Stroke (2012) 1.14
Treatment costs and indirect costs of cluster headache: A health economics analysis. Cephalalgia (2011) 1.11
Predicting outcome after acute ischemic stroke: an external validation of prognostic models. Neurology (2004) 1.10
Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy. J Neurosci (2007) 1.10
Guidelines for the organization of headache education in Europe: the headache school. Funct Neurol (2005) 1.09
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline. J Neurol Sci (2013) 1.08
Validation of a Georgian language headache questionnaire in a population-based sample. J Headache Pain (2007) 1.08
Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial. Arterioscler Thromb Vasc Biol (2006) 1.07
Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study. Cephalalgia (2011) 1.06